首页|乳腺癌改良根治术后患者血清PRL、CA125、VEGF的表达及复发转移的预测价值

乳腺癌改良根治术后患者血清PRL、CA125、VEGF的表达及复发转移的预测价值

扫码查看
目的:探讨乳腺癌改良根治术后患者血清泌乳素(PRL)、糖类抗原125(CA125)、内皮生长因子(VEGF)的表达及复发转移的预测价值。方法:选取2020年8月至2023年1月本院收治的行乳腺癌改良根治术70例乳腺癌患者作为观察组,纳入同期70例良性乳腺疾病患者作为对照组。对比两组PRL、CA125、VEGF表达水平,对观察组患者跟踪随访12个月,根据乳腺癌是否复发转移将观察组分为复发转移组(n=15)和未复发转移组(n=55),对比两组患者临床资料及PRL、CA125、VEGF表达水平,绘制ROC曲线,分析乳腺癌改良根治术后患者血清PRL、CA125、VEGF对复发转移的预测价值。结果:观察组PRL、CA125、VEGF水平高于对照组(P<0。05)。观察组中出现复发转移15例(21。43%)、未出现复发转移55例(78。57%);复发转移组HER2阳性、P53阳性患者人数占比高于未复发转移组,血清PRL、CA125、VEGF水平高于未复发转移组(P<0。05)。ROC曲线显示,PRL、CA125、VEGF3项指标联合预测乳腺癌改良根治术后复发转移的效能高于单一指标(AUC:0。857,95%CI:0。748~0。966)。结论:血清PRL、CA125、VEGF在乳腺癌患者及乳腺癌改良根治术后复发转移中均呈高表达,三项联合检测对乳腺癌改良根治术后复发转移具有较高预测价值。
Expression of serum PRL,CA125 and VEGF after modified radical surgery for breast cancer and its predictive value for recurrence and metastasis
Objective:To investigate the expression of serum prolactin(PRL),carbohydrate antigen 125(CA125)and endothe-lial growth factor(VEGF)in patients with breast cancer after modified radical surgery and the predictive value of recurrence and metastasis.Methods From August 2020 to January 2023,70 patients with breast cancer who underwent modified radical mastectomy were selected as the observation group,and 70 patients with benign breast diseases were included as the control group.The expression levels of PRL,CA125 and VEGF were compared between the two groups,and patients in the observa-tion group were followed up for 12 months.The observation group was divided into a recurrence and metastasis group(n=15)and a non-recurrence and metastasis group(n=55)according to whether breast cancer had recurred and metastasized.The clin-ical data and expression levels of PRL,CA125 and VEGF in the two groups were compared,and ROC curves were drawn.To analyze the value of serum PRL,CA125 and VEGF in predicting recurrence and metastasis after modified radical surgery for breast cancer.Results The levels of PRL,CA125 and VEGF in observation group were higher than those in control group(P<0.05).In the observation group,15 cases(21.43%)showed recurrence and metastasis,while 55 cases(78.57%)did not.The proportion of HER2 positive and P53 positive patients in the relapsed and metastatic group was higher than that in the non-relapsed and metastatic group,and the serum levels of PRL,CA125 and VEGF were higher than those in the non-relapsed and metastatic group(P<0.05).ROC curve showed that the combined efficacy of PRL,CA125 and VEGF3 indexes in pre-dicting recurrence and metastasis after modified radical breast cancer was higher than that of single index(AUC:0.857,95%CI:0.748~0.966).Conclusion Serum PRL,CA125 and VEGF are highly expressed in patients with breast cancer and in re-currence and metastasis after modified radical breast cancer surgery.The combined detection of PRL,CA125 and VEGF has high predictive value for recurrence and metastasis after modified radical breast cancer surgery.

Breast cancerModified radical operationPRLCA125VEGFRecurrence and metastasis

曾洪生

展开 >

金乡县人民医院,山东济宁 272200

乳腺癌 改良根治术 PRL CA125 VEGF 复发转移

2024

中外女性健康研究
武汉大学

中外女性健康研究

ISSN:2096-0417
年,卷(期):2024.(7)